Assessing Variability in Vascular Response to Cocoa With Personal Devices: A Series of Double-Blind Randomized Crossover n-of-1 Trials

被引:7
|
作者
Bapir, Mariam [1 ]
Campagnolo, Paola [2 ]
Rodriguez-Mateos, Ana [3 ]
Skene, Simon S. [1 ]
Heiss, Christian [1 ,4 ]
机构
[1] Univ Surrey, Fac Hlth & Med Sci, Dept Clin & Expt Med, Guildford, England
[2] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem Sci, Guildford, England
[3] Kings Coll London, Fac Life Sci & Med, Sch Life Course & Populat Sci, Dept Nutr Sci, London, England
[4] Surrey & Sussex NHS Healthcare Trust, Vasc Dept, Redhill, England
来源
FRONTIERS IN NUTRITION | 2022年 / 9卷
基金
英国经济与社会研究理事会;
关键词
cocoa flavanols; n-of-1; blood pressure; pulse wave velocity; variability; flow-mediated dilation; FLAVANOL-RICH COCOA; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FLAVONOID INTAKE; ASSOCIATIONS; FLAVAN-3-OLS; AMLODIPINE; RISK;
D O I
10.3389/fnut.2022.886597
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Controlled clinical intervention studies have demonstrated that cocoa flavanols (CF) can decrease blood pressure and arterial stiffness in healthy humans, although a large variability in the effect size across trials has been reported. In this study, we evaluated the intra- and inter-individual variability of responses to CF in everyday life using a series of n-of-1 trials in healthy free-living individuals with normal blood pressure carrying personal devices. In total, eleven healthy young humans participated in a repeated crossover randomized controlled double-blind n-of-1 trial. On 8 consecutive days, each volunteer consumed on alternating days 6 CF capsules (862 mg CF) on 4 days and 6 matched placebo capsules (P, 0 mg CF/day) on another 4 days in one of the two randomized sequences (CF-P-CF-P-CF-P-CF-P or P-CF-P-CF-P-CF-P-CF). On each day, the capsules were taken at the same time in the morning with breakfast after baseline measurements. Each subject was provided with an upper arm blood pressure monitor and a finger clip that measures pulse wave velocity (PWV). Measurements of blood pressure, heart rate, and PWV were taken at least hourly over 12 h during the day by the participants. On the first 2 days, measurements were performed under supervision to provide training. The overall mixed model analysis showed that CF significantly decreased 12-h systolic blood pressure and PWV by -1.4 +/- 0.3 mmHg and -0.11 +/- 0.03 m/s, respectively. Peak effects were observed within the first 3 h (1.5 h SBP: -4.9 +/- 2.2 mmHg, PWV: -0.32 +/- 0.17 m/s) and again after 8 h post-ingestion. Large inter-individual variation in responses was found [intra-cluster correlation coefficients (ICC): 0.41, 0.41]. When analyzing single individuals' datasets, there was also considerable between-day variation in individual responses that varied greatly between subjects (ICC: 0-0.30, 0-0.22, 0-0.45). Effect sizes inversely correlated with baseline blood pressure values both between- and within-subjects. The data confirm that cocoa can decrease blood pressure and arterial stiffness in everyday life when elevated within the normal range. The large inter- and intra-individual variation in responses calls for more personalized nutritional intervention strategies.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Ketanserin Reverses the Acute Response to LSD in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Participants
    Becker, Anna M.
    Klaiber, Aaron
    Holze, Friederike
    Istampoulouoglou, Ioanna
    Duthaler, Urs
    Varghese, Nimmy
    Eckert, Anne
    Liechti, Matthias E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2023, 26 (02): : 97 - 106
  • [42] Hormonal response to dehydroepiandrosterone administration in schizophrenia - Findings from a randomized, double-blind, placebo-controlled, crossover study
    Strous, Rael David
    Gibel, Anatoly
    Maayan, Rachel
    Weizman, Abraham
    Ritsner, Michael S.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (04) : 456 - 459
  • [43] Author response: Cerebello-spinal tDCS in ataxia: A randomized, double-blind, sham-controlled, crossover trial
    Benussi, Alberto
    Borroni, Barbara
    NEUROLOGY, 2019, 92 (23) : 1122 - 1122
  • [44] Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial
    Pasqua, Melissa-Rosina
    Tsoukas, Michael A.
    Kobayati, Alessandra
    Aboznadah, Wedyan
    Jafar, Adnan
    Haidar, Ahmad
    NATURE MEDICINE, 2025, : 1239 - 1245
  • [45] Comparative effectiveness of antihypertensive treatment for older children with primary hypertension: study protocol for a series of n-of-1 randomized trials
    Samuel, Joyce P.
    Samuels, Joshua A.
    Brooks, Lauren E.
    Bell, Cynthia S.
    Pedroza, Claudia
    Molony, Donald A.
    Tyson, Jon E.
    TRIALS, 2016, 17
  • [46] Daily socket comfort in transtibial amputee with a vacuum-assisted suspension system: study protocol of a randomized, multicenter, double-blind multiple N-of-1 trial
    Klotz, Remi
    Emile, Guilhem
    Daviet, Jean-Christophe
    De Seze, Mathieu
    Godet, Julien
    Urbinelli, Renaud
    Krasny-Pacini, Agata
    BMC SPORTS SCIENCE MEDICINE AND REHABILITATION, 2023, 15 (01)
  • [47] Comparative effectiveness of antihypertensive treatment for older children with primary hypertension: study protocol for a series of n-of-1 randomized trials
    Joyce P. Samuel
    Joshua A. Samuels
    Lauren E. Brooks
    Cynthia S. Bell
    Claudia Pedroza
    Donald A. Molony
    Jon E. Tyson
    Trials, 17
  • [48] Time to Antidepressant Response in Double-Blind, Randomized, Placebo-Controlled Trials of Brexanolone Injection in Postpartum Depression
    Meltzer-Brody, Samantha
    Bankole, Kemi
    Riesenberg, Robert
    Epperson, C. Neill
    Deligiannidis, Kristina
    Rubinow, David
    Li, Haihong
    Weedin, Nathan
    Kanes, Stephen
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 305 - 306
  • [49] PERSONAL: Feasibility Study Protocol for Placebo-Controlled, Randomized n-of-1 Trials of Tamsulosin for Lower Urinary Tract Symptoms
    Bauer, Scott R.
    Breyer, Benjamin N.
    Oni-Orisan, Akinyemi
    Steinman, Michael A.
    Sim, Ida
    McCulloch, Charles E.
    Kenfield, Stacey A.
    FRONTIERS IN DIGITAL HEALTH, 2020, 2
  • [50] Randomized, Double-blind Controlled Trial Assessing The Dose Response And Safety Of Deflazacort In Boys With Duchenne Muscular Dystrophy
    Reddy, Chaithanya
    Suthar, Renu
    Patil, Amol
    Saxena, Somya
    Saini, Arushi G.
    Sankhyan, Naveen
    Sankhyan, Naveen
    NEUROLOGY, 2021, 96 (15)